This is especially as more capital is needed for these pharmaceutical and biotech companies to eventually be ready for public use. Developing new solutions for unmet medical needs, which could be new drugs, medical technologies or digital health initiatives, requires not just plenty of scientific expertise but also significant backing from patient capital, he adds.
Healthcare is one of the sectors with strong private capital investments and with the rapid growth of innovation and the need to streamline costs, deals in the private market have grown significantly.
About 95% of the investment opportunities in healthcare lie in the private markets, says Yann Mauron, thematic private equity manager at Pictet Alternative Advisors.
